CN Patent

CN101636145B — 长期24小时经肠给予左旋多巴/卡比多巴

Assigned to Abbott Products GmbH · Expires 2014-04-23 · 12y expired

What this patent protects

治疗帕金森病的方法，其包括在大于16小时的期间内连续将药学上有效量的组合物经肠给予有此需要的患者，所述组合物包含左旋多巴并任选包含卡比多巴。

USPTO Abstract

治疗帕金森病的方法，其包括在大于16小时的期间内连续将药学上有效量的组合物经肠给予有此需要的患者，所述组合物包含左旋多巴并任选包含卡比多巴。

Drugs covered by this patent

Patent Metadata

Patent number
CN101636145B
Jurisdiction
CN
Classification
—
Expires
2014-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Products GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.